fam-trastuzumab deruxtecan
Restricted to use in outpatient infusion setting. Insurance certification or PAP eligibility review required with each case before use. May be administered as "patient own medication" through PAP.
Reviewed: March 2021 (Enhertu)
Restricted to use in outpatient infusion setting. Insurance certification or PAP eligibility review required with each case before use. May be administered as "patient own medication" through PAP.
Reviewed: March 2021 (Enhertu)